Philips expands collaborations to support connected patient monitoring

  • August 26, 2026
  • Esther Shein

With an eye on supporting connected patient monitoring from hospital to home, Royal Philips has announced several new collaborations to expand its open monitoring ecosystem. The partnerships the company announced are with: Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree, and smartQare.

The collaborations is designed to help health systems improve continuity and coordination of care by integrating wearable and out-of-hospital technologies into the Philips ecosystem. Maintaining visibility into patient status across the care continuum has become increasingly important as healthcare systems expand higher-acuity services beyond traditional hospital settings.

Philips is joining this transition through an interoperable monitoring ecosystem that aims to give health systems greater flexibility to deploy and scale monitoring programs using the technologies that best fit their clinical and operational needs. By connecting patient data across care settings, Philips’ goal is to transform data into actionable care intelligence, supporting more efficient care coordination throughout the patient’s journey.   

“Monitoring is no longer just about what happens at the bedside. Healthcare organizations need a more connected approach that helps clinicians maintain visibility into patient status across care settings,” said Sangdo Kim, category leader, nextgen acute and transitional care monitoring, at Philips. “By building an open, enterprise-wide ecosystem that connects technologies, data and workflows, we can help deliver continuous patient insight, support smoother transitions in care, and create a more coordinated experience for clinicians and patients.”

The partnerships expand the range of continuous patient measurements that can be integrated into Philips ecosystem, such as the Patient Information Center (PIC) iX. The partnerships include the following products: 
 

  • Blue Spark Technologies – TempTraq wearable disposable patch aims to support continuous core body temperature monitoring to detect fevers earlier to enable improved patient visibility and early intervention, both inpatient and outpatient.
  • Caretaker Medical – VitalStream wearable is designed to support continuous non-invasive blood pressure and advanced hemodynamic monitoring to help enhance inpatient surveillance and clinical decision-making.
  • Cuviva – a core hospital-at-home platform technology partner, was built to deliver a secure, advanced and fully integrated IT platform that enables structured, scalable hospital-at-home care through digital monitoring, real-time communication, and smooth integration with the Philips clinical workflows as well as hospitals’ digital infrastructure.
  • LifeSignals – UbiqVue Multiparameter Biosensor, a single-use, wireless, wearable, chest-based device was designed to support continuous, near real-time monitoring of 2-channel ECG, SpO₂, pulse rate, respiration rate, body temperature, posture and motion. Coupled with centralized software, it was develop to enable alert-driven, scalable, active patient monitoring across hospital and out-of-hospital settings.
  • Respiree – 1Bio(TM) platform + 1Bio(TM)AI + RS001 wearable biosensor technology was designed to enable continuous cardio-respiratory monitoring, including patented direct respiratory rate and other lung physiological markers, pulse, SpO2, posture, and activity, helping support earlier identification of patient deterioration across care settings.
  • smartQare – viQtor & Healthdot wearable biosensor technologies was built to support continuous monitoring of pulse, respiration, SpO2, skin temperature, and activity to help clinicians maintain visibility into patient status across care transitions.

These added capabilities complement Philips’ broader connected care portfolio, which includes systems that aim to support monitoring beyond discharge, the company said. Philips Mobile Cardiac Telemetry (MCOT) is designed to enable clinicians to remotely monitor appropriate cardiac patients for up to 30 days following an inpatient or ED evaluation, with the intention of supporting smoother transitions into the appropriate care pathway.